Immuneering Ownership 2024 | Who Owns Immuneering Now?
Institutional Ownership
2.85%
Insider Ownership
29.15%
Retail Ownership
67.99%
Institutional Holders
14.00
Immuneering Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 3.64% | - | 1,070,322 | -133,344 | -11.08% | 1,370,013 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.25% | 0.00% | 953,226 | 889,964 | 1406.79% | 1,220,129 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.93% | 0.00% | 859,374 | -50,892 | -5.59% | 1,100,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.52% | 0.00% | 741,548 | 287,315 | 63.25% | 949,181 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.87% | 0.21% | 550,000 | 550,000 | 100.00% | 704,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.82% | - | 533,364 | -843,756 | -61.27% | 682,707 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.31% | 0.00% | 384,075 | 384,075 | 100.00% | 491,617 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.19% | 0.00% | 349,100 | 349,100 | 100.00% | 446,848 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% | - | 221,801 | -240,719 | -52.05% | 283,976 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.72% | 0.00% | 210,025 | 210,025 | 100.00% | 268,832 | Jun 30, 2024 |
| SOUTHPORT MANAGEMENT, L.L.C. | 0.55% | 0.92% | 160,100 | 70,000 | 77.69% | 204,928 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.54% | - | 158,917 | -17,088 | -9.71% | 203,414,000 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.51% | 0.00% | 150,876 | - | - | 193,121 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.28% | 0.00% | 82,638 | -4,686 | -5.37% | 105,777 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.26% | 0.00% | 74,939 | -23,315 | -23.73% | 95,922 | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | 0.25% | 0.00% | 74,250 | 41,000 | 123.31% | 95,040 | Jun 30, 2024 |
| STATE STREET CORP | 0.24% | - | 69,235 | -307,661 | -81.63% | 88,621,000 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.20% | 0.00% | 59,960 | 59,960 | 100.00% | 76,749 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.18% | 0.00% | 53,949 | -60,100 | -52.70% | 69,055 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.18% | 0.00% | 53,445 | 53,445 | 100.00% | 67,000 | Jun 30, 2024 |
Immuneering's largest institutional shareholder is VANGUARD GROUP INC, holding 3.64% of the company's total share outstanding, currently valued at $1.37M. The top 10 institutional shareholders own together 20.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOUTHPORT MANAGEMENT, L.L.C. | 0.55% | 0.92% | 160,100 | 70,000 | 77.69% | 204,928 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.87% | 0.21% | 550,000 | 550,000 | 100.00% | 704,000 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.04% | 0.01% | 11,806 | 11,806 | 100.00% | 15,112 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.01% | 34,609 | 34,609 | 100.00% | 44,300 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.20% | 0.00% | 59,960 | 59,960 | 100.00% | 76,749 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.00% | 34,159 | 9,274 | 37.27% | 43,724 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.26% | 0.00% | 74,939 | -23,315 | -23.73% | 95,922 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.18% | 0.00% | 53,949 | -60,100 | -52.70% | 69,055 | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 2,560 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.16% | 0.00% | 45,811 | 45,811 | 100.00% | 58,638 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.19% | 0.00% | 349,100 | 349,100 | 100.00% | 446,848 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.31% | 0.00% | 384,075 | 384,075 | 100.00% | 491,617 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.06% | 0.00% | 18,203 | 18,203 | 100.00% | 23,300 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.72% | 0.00% | 210,025 | 210,025 | 100.00% | 268,832 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.25% | 0.00% | 953,226 | 889,964 | 1406.79% | 1,220,129 | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | 0.25% | 0.00% | 74,250 | 41,000 | 123.31% | 95,040 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 12,067 | 7,174 | 146.62% | 15,446 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.00% | 4,983 | 4,983 | 100.00% | 6,378 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.18% | 0.00% | 53,445 | 53,445 | 100.00% | 67,000 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.51% | 0.00% | 150,876 | - | - | 193,121 | Jun 30, 2024 |
The largest Immuneering shareholder by % of total assets is SOUTHPORT MANAGEMENT, L.L.C.. The company owns 160.10K shares of Immuneering (IMRX), representing 0.92% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 3.25% | 0.00% | 953,226 | 889,964 | 1406.79% | 1,220,129 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.87% | 0.21% | 550,000 | 550,000 | 100.00% | 704,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.31% | 0.00% | 384,075 | 384,075 | 100.00% | 491,617 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.19% | 0.00% | 349,100 | 349,100 | 100.00% | 446,848 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.52% | 0.00% | 741,548 | 287,315 | 63.25% | 949,181 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.72% | 0.00% | 210,025 | 210,025 | 100.00% | 268,832 | Jun 30, 2024 |
| SOUTHPORT MANAGEMENT, L.L.C. | 0.55% | 0.92% | 160,100 | 70,000 | 77.69% | 204,928 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.20% | 0.00% | 59,960 | 59,960 | 100.00% | 76,749 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.18% | 0.00% | 53,445 | 53,445 | 100.00% | 67,000 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.16% | 0.00% | 45,811 | 45,811 | 100.00% | 58,638 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.15% | 0.00% | 43,960 | 43,960 | 100.00% | 57,000 | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | 0.25% | 0.00% | 74,250 | 41,000 | 123.31% | 95,040 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.01% | 34,609 | 34,609 | 100.00% | 44,300 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | 0.00% | 24,262 | 24,262 | 100.00% | 31,055 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.07% | 0.00% | 21,364 | 21,364 | 100.00% | 27,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.11% | - | 32,115 | 19,112 | 146.98% | 41,108 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.06% | 0.00% | 18,203 | 18,203 | 100.00% | 23,300 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.04% | 0.01% | 11,806 | 11,806 | 100.00% | 15,112 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | - | 11,389 | 11,389 | 100.00% | 14,578 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | - | 10,813 | 10,813 | 100.00% | 13,840 | Jun 30, 2024 |
As of Jun 30 2024, Immuneering's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 889.96K stocks of IMRX, valued at $1.22M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -3,295,273 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 1.82% | - | 533,364 | -843,756 | -61.27% | 682,707 | Jun 30, 2024 |
| STATE STREET CORP | 0.24% | - | 69,235 | -307,661 | -81.63% | 88,621,000 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -254,513 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% | - | 221,801 | -240,719 | -52.05% | 283,976 | Jun 30, 2024 |
| FMR LLC | 0.02% | - | 6,743 | -226,455 | -97.11% | 8,631 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.64% | - | 1,070,322 | -133,344 | -11.08% | 1,370,013 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -60,512 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.18% | 0.00% | 53,949 | -60,100 | -52.70% | 69,055 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -53,778 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.93% | 0.00% | 859,374 | -50,892 | -5.59% | 1,100,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -44,049 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -26,536 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.26% | 0.00% | 74,939 | -23,315 | -23.73% | 95,922 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 7,053 | -21,898 | -75.64% | 9,027 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.05% | - | 13,366 | -17,983 | -57.36% | 17,223 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,386 | -17,546 | -83.82% | 4,333 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.54% | - | 158,917 | -17,088 | -9.71% | 203,414,000 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -16,055 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Immuneering's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -3.30M shares of IMRX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 1.87% | 0.21% | 550,000 | 550,000 | 100.00% | 704,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.31% | 0.00% | 384,075 | 384,075 | 100.00% | 491,617 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.19% | 0.00% | 349,100 | 349,100 | 100.00% | 446,848 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.72% | 0.00% | 210,025 | 210,025 | 100.00% | 268,832 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.20% | 0.00% | 59,960 | 59,960 | 100.00% | 76,749 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.18% | 0.00% | 53,445 | 53,445 | 100.00% | 67,000 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.16% | 0.00% | 45,811 | 45,811 | 100.00% | 58,638 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.01% | 34,609 | 34,609 | 100.00% | 44,300 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | 0.00% | 24,262 | 24,262 | 100.00% | 31,055 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.07% | 0.00% | 21,364 | 21,364 | 100.00% | 27,000 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.06% | 0.00% | 18,203 | 18,203 | 100.00% | 23,300 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.04% | 0.01% | 11,806 | 11,806 | 100.00% | 15,112 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | - | 11,389 | 11,389 | 100.00% | 14,578 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | - | 10,813 | 10,813 | 100.00% | 13,840 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.02% | - | 6,594 | 6,594 | 100.00% | 8,440 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.00% | 5,850 | 5,850 | 100.00% | 7,488 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.00% | 4,983 | 4,983 | 100.00% | 6,378 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.02% | - | 4,509 | 4,509 | 100.00% | 5,772,000 | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 2,560 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 1,136 | 1,136 | 100.00% | 1,454 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | - | 345 | 345 | 100.00% | 390 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.00% | - | 80 | 80 | 100.00% | 94 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | 10 | 10 | 100.00% | 13 | Jun 30, 2024 |
Immuneering's largest new institutional shareholder by number of shares is PROSIGHT MANAGEMENT, LP, purchased 550.00K shares, valued at $704.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -3,295,273 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -254,513 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -60,512 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -53,778 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -44,049 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -26,536 | -100.00% | - | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -16,055 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -11,526 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -11,382 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -11,034 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -9,669 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -6,974 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -2,542 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,168 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -1,675 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -784 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -684 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Immuneering's largest sold out institutional shareholder by shares sold is CORMORANT ASSET MANAGEMENT, LP, sold -3.30M shares, valued at -, as of undefined.
Immuneering Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | 0.30% | 1,510,552 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.18% | 604,339 | -518,280 | -46.17% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.13% | 335,561 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.06% | 14,456 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 109,949 | 75,000 | 214.60% | Mar 28, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.04% | 318,851 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,162 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 29,046 | -22,500 | -43.65% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 38,116 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,190 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 37,971 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,141 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 269,585 | -219,700 | -44.90% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,025,384 | -167,048 | -14.01% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 60,512 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 198,169 | 4,700 | 2.43% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 20,490 | 3,283 | 19.08% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,915 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,675 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,649 | -1,133 | -6.03% | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 3,470 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,303 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 11,118 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,899 | -1,499 | -15.95% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 168 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,500 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 11,565 | 169 | 1.48% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,658 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 7,361 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 8,332 | -1,831 | -18.02% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,186 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 61,941 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 101,261 | 12,401 | 13.96% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 762,363 | -43,151 | -5.36% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 185 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 264,380 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 8,592 | -34 | -0.39% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,973 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 354 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,574 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,369 | -599 | -15.10% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 92 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 1,459 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 8,274 | 2,461 | 42.34% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 101 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 34,814 | -3,858 | -9.98% | Mar 31, 2024 |
| ProFunds | 0.00% | 174 | -14 | -7.45% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,280 | -1,478 | -31.06% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,835 | 520 | 22.46% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 12,386 | 6,193 | 100.00% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 12 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 752 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 10,169 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 27,824 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,160 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 17,200 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 414 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,536 | -11 | -0.43% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 650 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 5,460 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 12,765 | 1,272 | 11.07% | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 37,414 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 7,060 | -11,507 | -61.98% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 526 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 5,376 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 60 | 9 | 17.65% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,511 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,657 | 320 | 13.69% | Jan 31, 2024 |
Immuneering's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.51M shares, compromising 0.30% of its total assets.
Immuneering Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -72.00% |
| 31 Mar, 24 | 50 | -3.85% |
| 31 Dec, 23 | 52 | -1.89% |
| 30 Sep, 23 | 53 | 8.16% |
| 30 Jun, 23 | 49 | 44.12% |
| 31 Mar, 23 | 34 | 6.25% |
| 31 Dec, 22 | 32 | - |
| 30 Sep, 22 | 32 | -3.03% |
| 30 Jun, 22 | 33 | -32.65% |
| 31 Mar, 22 | 49 | 32.43% |
| 31 Dec, 21 | 37 | -2.63% |
| 30 Sep, 21 | 38 | - |
As of 30 Jun 24, 14 institutions are holding Immuneering's shares, representing a decrease of -72.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 838,215 | -92.94% |
| 31 Mar, 24 | 11,871,552 | -26.40% |
| 31 Dec, 23 | 16,130,676 | -4.79% |
| 30 Sep, 23 | 16,941,765 | -1.90% |
| 30 Jun, 23 | 17,269,968 | 46.06% |
| 31 Mar, 23 | 11,823,558 | 0.86% |
| 31 Dec, 22 | 11,722,865 | -2.83% |
| 30 Sep, 22 | 12,063,771 | -0.70% |
| 30 Jun, 22 | 12,149,084 | -10.75% |
| 31 Mar, 22 | 13,612,091 | 8.89% |
| 31 Dec, 21 | 12,500,950 | 3.27% |
| 30 Sep, 21 | 12,105,231 | - |
Immuneering (IMRX) has 838.22K shares outstanding as of 30 Jun 24, down -92.94% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 2.85% | 0.17% |
| 31 Mar, 24 | 40.56% | 1.34% |
| 31 Dec, 23 | 55.12% | 1.58% |
| 30 Sep, 23 | 59.14% | 1.39% |
| 30 Jun, 23 | 65.31% | 3.27% |
| 31 Mar, 23 | 44.71% | 2.27% |
| 31 Dec, 22 | 44.43% | 2.13% |
| 30 Sep, 22 | 45.71% | 2.16% |
| 30 Jun, 22 | 46.04% | 1.73% |
| 31 Mar, 22 | 51.64% | 2.23% |
| 31 Dec, 21 | 48.12% | 1.10% |
| 30 Sep, 21 | 66.20% | - |
As of 30 Jun 24, Immuneering is held by 2.85% institutional shareholders, representing a 0.17% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -50.00% |
| 31 Mar, 24 | 20 | -4.76% |
| 31 Dec, 23 | 21 | -34.38% |
| 30 Sep, 23 | 32 | -17.95% |
| 30 Jun, 23 | 39 | 95.00% |
| 31 Mar, 23 | 20 | 25.00% |
| 31 Dec, 22 | 16 | 6.67% |
| 30 Sep, 22 | 15 | 36.36% |
| 30 Jun, 22 | 11 | -70.27% |
| 31 Mar, 22 | 37 | 54.17% |
| 31 Dec, 21 | 24 | -36.84% |
| 30 Sep, 21 | 38 | - |
10 institutional shareholders have increased their position in IMRX stock as of 30 Jun 24 compared to 20 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -87.50% |
| 31 Mar, 24 | 24 | 33.33% |
| 31 Dec, 23 | 18 | 63.64% |
| 30 Sep, 23 | 11 | 83.33% |
| 30 Jun, 23 | 6 | -50.00% |
| 31 Mar, 23 | 12 | 9.09% |
| 31 Dec, 22 | 11 | -8.33% |
| 30 Sep, 22 | 12 | -40.00% |
| 30 Jun, 22 | 20 | 233.33% |
| 31 Mar, 22 | 6 | 50.00% |
| 31 Dec, 21 | 4 | - |
| 30 Sep, 21 | - | - |
3 institutional shareholders have reduced their position in IMRX stock as of 30 Jun 24 compared to 24 in the previous quarter (a -87.50% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 14 | -72.00% | 838,215 | -92.94% | 2.85% | 0.17% | 10 | -50.00% | 3 | -87.50% |
| 31 Mar, 24 | 50 | -3.85% | 11,871,552 | -26.40% | 40.56% | 1.34% | 20 | -4.76% | 24 | 33.33% |
| 31 Dec, 23 | 52 | -1.89% | 16,130,676 | -4.79% | 55.12% | 1.58% | 21 | -34.38% | 18 | 63.64% |
| 30 Sep, 23 | 53 | 8.16% | 16,941,765 | -1.90% | 59.14% | 1.39% | 32 | -17.95% | 11 | 83.33% |
| 30 Jun, 23 | 49 | 44.12% | 17,269,968 | 46.06% | 65.31% | 3.27% | 39 | 95.00% | 6 | -50.00% |
| 31 Mar, 23 | 34 | 6.25% | 11,823,558 | 0.86% | 44.71% | 2.27% | 20 | 25.00% | 12 | 9.09% |
| 31 Dec, 22 | 32 | - | 11,722,865 | -2.83% | 44.43% | 2.13% | 16 | 6.67% | 11 | -8.33% |
| 30 Sep, 22 | 32 | -3.03% | 12,063,771 | -0.70% | 45.71% | 2.16% | 15 | 36.36% | 12 | -40.00% |
| 30 Jun, 22 | 33 | -32.65% | 12,149,084 | -10.75% | 46.04% | 1.73% | 11 | -70.27% | 20 | 233.33% |
| 31 Mar, 22 | 49 | 32.43% | 13,612,091 | 8.89% | 51.64% | 2.23% | 37 | 54.17% | 6 | 50.00% |
| 31 Dec, 21 | 37 | -2.63% | 12,500,950 | 3.27% | 48.12% | 1.10% | 24 | -36.84% | 4 | - |
| 30 Sep, 21 | 38 | - | 12,105,231 | - | 66.20% | - | 38 | - | - | - |
Immuneering Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Immuneering's stock was made by Bookman Michael on May 23 2024, selling 143,000 shares at $4.25 per share (valued at $607.75K).
Immuneering Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 21 | 23 | 91.30% |
| Q1 2024 | 26 | 5 | 520.00% |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 8 | - | - |
| Q4 2022 | 2 | 1 | 200.00% |
| Q3 2022 | 1 | 4 | 25.00% |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 13 | 1 | 1300.00% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 25 | 35 | 71.43% |
| Q3 2008 | - | 1 | - |
| Q2 2008 | 2 | - | - |
| Q4 2007 | 2 | - | - |
| Q3 2007 | 3 | 1 | 300.00% |
21 total buy trades, and 23 total sell trades (buy/sell ratio of 0.91%) were made by Immuneering's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 8 | - |
| Q1 2024 | 12 | 5 | 240.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 4 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 16 | - | - |
| Q3 2008 | - | - | - |
| Q2 2008 | - | - | - |
| Q4 2007 | - | - | - |
| Q3 2007 | 1 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Immuneering's stocks.
Immuneering Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| GOSS | Gossamer Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| IVA | Inventiva S.A. |
| CNTA | Centessa Pharmaceuticals plc |
| IKNA | Ikena Oncology, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| KRON | Kronos Bio, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| LYRA | Lyra Therapeutics, Inc. |
| CELC | Celcuity Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| CMPX | Compass Therapeutics, Inc. |
| ELVN | Enliven Therapeutics, Inc. |
IMRX Ownership FAQ
Who Owns Immuneering?
Immuneering is owned by institutional shareholders (2.85%), insiders (29.15%), and public (67.99%). The largest institutional shareholder of Immuneering is VANGUARD GROUP INC (3.64% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.30% of total shares).
Who are the major institutional shareholders of Immuneering?
Immuneering's major institutional shareholders are VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, GOLDMAN SACHS GROUP INC, and PROSIGHT MANAGEMENT, LP. The top five shareholders own together 14.21% of the company's share outstanding.
How many Immuneering shareholders are there?
As of Jun 2024, there are 14 institutional shareholders of Immuneering.
What percentage of Immuneering is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 1.07M shares of Immuneering, representing 3.64% of the company's total shares outstanding, valued at $1.37M (as of Jun 2024).
What percentage of Immuneering is owned by MILLENNIUM MANAGEMENT LLC?
As of Jun 2024, MILLENNIUM MANAGEMENT LLC holds 953.23K shares of Immuneering (IMRX), compromising 3.25% of the company, valued at $1.22M.
What percentage of Immuneering is owned by PRICE T ROWE ASSOCIATES INC /MD/?
PRICE T ROWE ASSOCIATES INC /MD/ is the third largest holder of Immuneering. The company owns 859.37K of the company's shares outstanding (worth $1.1M).